Describe the biosynthesis of haem and its regulation. Classify the porphyrias and add a note on lead poisoning.
Introduction
Haem = a porphyrin ring (protoporphyrin IX) chelating ferrous iron; the prosthetic group of haemoglobin, myoglobin, cytochromes, catalase, peroxidase and cytochrome P450.
- Synthesised chiefly in the bone marrow (85%) and liver (15%)
- Begins and ends in the mitochondrion, with the middle steps in the cytosol
Pathway
Succinyl-CoA + Glycine (mitochondrion) → ala synthase — needs pyridoxal phosphate; rate-limiting → δ-Aminolaevulinic acid (ala) → moves to cytosol → ala dehydratase — inhibited by lead → Porphobilinogen → Uroporphyrinogen I synthase and III cosynthase → Uroporphyrinogen III → Coproporphyrinogen III → back to mitochondrion → Protoporphyrin IX → ferrochelatase — adds Fe2+; also inhibited by lead → haem
- All eight carbons and four nitrogens come from succinyl-CoA and glycine
- Haem inhibits ala synthase by feedback, and also represses its gene — the principal control
Regulation
| Ala synthase induced by | Ala synthase inhibited by |
|---|---|
| Drugs inducing cytochrome P450 — barbiturates, phenytoin, griseofulvin, sulphonamides, rifampicin | Haem (feedback) |
| Fasting and low carbohydrate intake | Glucose (the "glucose effect") |
| Alcohol | — |
| Steroid hormones — hence attacks around menstruation | — |
| Infection, stress, surgery | — |
CLINICAL PEARL
This regulation explains the whole clinical picture of acute porphyria. Anything that induces P450 consumes haem, releasing ala synthase from inhibition. The enzyme is up-regulated, precursors accumulate above the block, and an attack follows. It also explains the two treatments — glucose and haem arginate, both of which switch the enzyme off.
Classification of Porphyrias
| Type | Enzyme deficient | Site | Chief features |
|---|---|---|---|
| Acute intermittent porphyria | Porphobilinogen deaminase (uroporphyrinogen I synthase) | Hepatic | Abdominal pain, neuropsychiatric features; NO photosensitivity |
| Congenital erythropoietic porphyria | Uroporphyrinogen III cosynthase | Erythropoietic | Severe photosensitivity, red urine, red teeth, haemolysis |
| Porphyria cutanea tarda | Uroporphyrinogen decarboxylase | Hepatic | The commonest; photosensitivity, blistering; alcohol and hepatitis C |
| Hereditary coproporphyria | Coproporphyrinogen oxidase | Hepatic | Acute attacks and photosensitivity |
| Variegate porphyria | Protoporphyrinogen oxidase | Hepatic | Both; common in South Africa |
| Erythropoietic protoporphyria | Ferrochelatase | Erythropoietic | Burning photosensitivity without blisters |
- The rule is simple: a block early in the pathway accumulates ala and porphobilinogen, which are neurotoxic; a block later accumulates porphyrins, which are photosensitising
Acute Intermittent Porphyria
- Autosomal dominant; attacks usually after puberty, commoner in women
- The five Ps — Pain in the abdomen, Polyneuropathy, Psychological disturbance, Port-wine urine, Precipitated by drugs
- Severe colicky abdominal pain with NO peritoneal signs — many patients undergo needless laparotomy
- Tachycardia, hypertension, vomiting, constipation; hyponatraemia from SIADH
- Urine darkens to port-wine colour on standing in light, as porphobilinogen polymerises
- Diagnosis — raised urinary ala and porphobilinogen; the Watson–Schwartz test
- Treatment — withdraw the precipitant, intravenous glucose, haem arginate, analgesia, and propranolol for the autonomic features
Lead Poisoning
Lead inhibits ala dehydratase and ferrochelatase → Two consequences → ala accumulates → neurotoxicity → Protoporphyrin accumulates (iron cannot be inserted) → Zinc is inserted instead → ↑ zinc protoporphyrin → Microcytic anaemia with basophilic stippling
- Features — abdominal colic, peripheral neuropathy with wrist drop, encephalopathy in children, blue lead line on the gums, anaemia
- Raised blood lead, raised urinary ala, raised zinc protoporphyrin; porphobilinogen is normal, which distinguishes it from acute porphyria
- Treated with chelation — EDTA, dimercaprol, penicillamine, succimer
Catabolism of Haem
Haem from senescent red cells → Haem oxygenase — releases iron (reused) and CO → Biliverdin → biliverdin reductase → bilirubin → albumin-bound to liver → Conjugated with glucuronic acid → excreted in bile
- Iron and globin are conserved; only the porphyrin ring is degraded
- Carbon monoxide from haem breakdown is the only endogenous source, and is measurable in exhaled breath as an index of haemolysis
- 250–350 mg of bilirubin is produced daily
Applied Aspects
- Porphyria is a great mimic — consider it in unexplained abdominal pain with neuropsychiatric features, especially if attacks recur and investigations are normal
- A long list of drugs is unsafe — barbiturates, sulphonamides, phenytoin, oestrogens, griseofulvin; safe alternatives must be checked before prescribing
- Sideroblastic anaemia — from pyridoxine deficiency, isoniazid or lead, all interfering with haem synthesis; ring sideroblasts on marrow
- Porphyria cutanea tarda responds to venesection and to low-dose chloroquine, and is strongly associated with alcohol, hepatitis C and iron overload
- Photosensitivity arises because porphyrins absorb light at 400 nm (the Soret band) and generate free radicals in the skin
- Haem is also the prosthetic group of cytochrome P450, which is why drugs that induce P450 consume haem and precipitate attacks
- Ala synthase requires pyridoxal phosphate, so B6 deficiency and isoniazid cause sideroblastic anaemia
- Erythropoietic protoporphyria causes burning pain on sun exposure without blistering, and may progress to liver failure from protoporphyrin deposition
- Givosiran, a small interfering RNA that silences ala synthase, is a recent treatment for recurrent acute attacks — derived directly from the regulation described above
- Urine porphobilinogen must be measured during an attack; it may be normal between attacks, so a negative result in a well patient does not exclude the diagnosis
- Family screening is essential, since asymptomatic carriers can be warned about unsafe drugs before their first attack
- The porphyrias are often described as the "little imitator", and delayed diagnosis by years is common
All questions in Clinical & Applied Biochemistry
- Q1Classify the liver function tests. Describe the biochemical findings in the three types of jaundice. ★
- Q2Classify the renal function tests. Describe the assessment of glomerular filtration rate and the tests of tubular function. ★
- Q3Describe the biosynthesis of haem and its regulation. Classify the porphyrias and add a note on lead poisoning. ★
- Q4Classify the acid–base disorders. Describe their causes, compensation and the use of the anion gap. ★
- Q5Describe the formation, transport, conjugation and excretion of bilirubin. Classify jaundice and add a note on neonatal jaundice. ★
- SN1Classify the tumour markers with their clinical applications and limitations. ★
- SN2Describe the normal composition of cerebrospinal fluid and the changes in meningitis. ★
- SN3Describe the thyroid function tests and their interpretation. ★
- SN4Describe quality control in the clinical biochemistry laboratory. ★
- SN5Describe automation in the clinical biochemistry laboratory with its advantages and limitations.
- SN6Describe the principles and applications of therapeutic drug monitoring.
- SN7Describe the principles of biochemical screening with examples in the newborn and in pregnancy. ★